Back to Search Start Over

Rapid non-destructive volumetric tumor yield assessment in fresh lung core needle biopsies using polarization sensitive optical coherence tomography.

Authors :
Nandy S
Helland TL
Roop BW
Raphaely RA
Ly A
Lew M
Berigei SR
Villiger M
Sorokina A
Szabari MV
Fintelmann FJ
Suter MJ
Hariri LP
Source :
Biomedical optics express [Biomed Opt Express] 2021 Aug 13; Vol. 12 (9), pp. 5597-5613. Date of Electronic Publication: 2021 Aug 13 (Print Publication: 2021).
Publication Year :
2021

Abstract

Adequate tumor yield in core-needle biopsy (CNB) specimens is essential in lung cancer for accurate histological diagnosis, molecular testing for therapeutic decision-making, and tumor biobanking for research. Insufficient tumor sampling in CNB is common, primarily due to inadvertent sampling of tumor-associated fibrosis or atelectatic lung, leading to repeat procedures and delayed diagnosis. Currently, there is no method for rapid, non-destructive intraprocedural assessment of CNBs. Polarization-sensitive optical coherence tomography (PS-OCT) is a high-resolution, volumetric imaging technique that has the potential to meet this clinical need. PS-OCT detects endogenous tissue properties, including birefringence from collagen, and degree of polarization uniformity (DOPU) indicative of tissue depolarization. Here, PS-OCT birefringence and DOPU measurements were used to quantify the amount of tumor, fibrosis, and normal lung parenchyma in 42 fresh, intact lung CNB specimens. PS-OCT results were compared to and validated against matched histology in a blinded assessment. Linear regression analysis showed strong correlations between PS-OCT and matched histology for quantification of tumors, fibrosis, and normal lung parenchyma in CNBs. PS-OCT distinguished CNBs with low tumor content from those with higher tumor content with high sensitivity and specificity. This study demonstrates the potential of PS-OCT as a method for rapid, non-destructive, label-free intra-procedural tumor yield assessment.<br />Competing Interests: LPH: Boehringer Ingelheim, Pliant Therapeutics, LX Medical, and Biogen Idec. MJS: NinePoint Medical, LX Medical.<br /> (© 2021 Optical Society of America under the terms of the OSA Open Access Publishing Agreement.)

Details

Language :
English
ISSN :
2156-7085
Volume :
12
Issue :
9
Database :
MEDLINE
Journal :
Biomedical optics express
Publication Type :
Academic Journal
Accession number :
34692203
Full Text :
https://doi.org/10.1364/BOE.433346